Herpes zoster and subsequent risk of cancer: A population-based study

Journal of Epidemiology

Volumn 23, Issue 3, 2013, Pages 205-210

  Chiu, Hui Fen ^a   Chen, Brian K ^b   Yang, Chun Yuh ^c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cancer; Cohort study; Herpes zoster; Incidence; Risk

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; FACTUAL DATABASE; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM; RISK ASSESSMENT; TAIWAN; TIME; VIROLOGY;

AGED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HERPES ZOSTER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RISK ASSESSMENT; TAIWAN; TIME FACTORS;

MLCS; MLOWN;

EID: 84879975980     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20120155     Document Type: Article

References (22)

1. Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol. 2009;89:612-6.
2. Gilden DH, Cohrs RJ, Mahalingam R. Clinical and molecular pathogenesis of varicella virus infection. Viral Immunol. 2003;16:243-58.
3. LaGuardia JJ, Gilden DH. Varicella-zoster virus: a re-emerging infection. J Investig Dermatol Symp Proc. 2001;6:183-7.
4. Wyburn-Mason R. Malignant change arising in tissues affected by herpes. Br Med J. 1955;2:1106-9.
5. Smith JB, Fenske NA. Herpes zoster and internal malignancy. South Med J. 1995;88:1089-92.
6. Fueyo MA, Lookingbill DP. Herpes zoster and occult malignancy. J Am Acad Dermatol. 1984;11:480-2.
7. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Risk of cancer after herpes zoster: A population-based study. N Engl J Med. 1982;307:393-7.
8. Buntinx F, Wachana R, Bartholomeeusen S, Sweldens K, Geys H. Is herpes zoster a marker for occult or subsequent malignancy? Br J Gen Pract. 2005;55:102-7.
9. Sørensen HT, Olsen JH, Jepsen P, Johnsen SP, Schønheyder HC, Mellemkjaer L. The risk and prognosis of cancer after hospitalization for herpes zoster: A population-based follow-up study. Br J Cancer. 2004;91:1275-9.
10. Chen YC, Yeh HY. Taiwan's National Health Insurance Database: administrative health care database as study object in biblometrics. Scientometrics. 2011;86:365-80.
11. Tzeng GH, Wu TY. Characteristics of urbanization levels in Taiwan districts. Geographic Res. 1986;12:287-323.
12. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33:1674-85.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-9.
14. Hosmer DW, Lemeshow S. Applied survival analysis. New York: John Wiley & Sons, Inc; 1999. p. 317-26.
15. Rogers RS 3rd, Tindall JP. Geriatric herpes zoster. J Am Geriatr Soc. 1971;19:495-504.
16. Wolff HH, Wendt V, Winzer M. Cutaneous pseudolymphoma at the site of prior herpes zoster eruption. Arch Dermatol Res. 1987;279 Suppl:S52-4.
17. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005;352:2266-7.
18. Weller TH. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med. 1983;309:1434-40.
19. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21: 137-48.
20. Konjevic G, Jurisic V, Banicevic B, Spuzic I. The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease. Br J Haematol. 1999;104: 144-51.
21. Ho JD, Xirasagar S, Lin HC. Increased risk of a cancer diagnosis after herpes zoster ophthalmicus: A nationwide population-based study. Ophthalmology. 2011;118:1076-81.
22. Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: A population-based follow-up study. Neurology. 2010;74:792-7.